Whanin Pharm (016580) — Cash Flow Quality Index
Whanin Pharm (016580) has a Cash Flow Quality Index of 1.20x as of June 2026. Operating cash flow of ₩9.26 Billion exceeds net income of ₩7.70 Billion, indicating high earnings quality where cash backs reported profits. Explore 016580 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Whanin Pharm Cash Flow Quality Index (2009–2025)
Historical Cash Flow Quality Index for Whanin Pharm across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Whanin Pharm operating cash flow efficiency.
Annual Cash Flow Quality Index for Whanin Pharm (2009–2025)
Year-by-year earnings quality comparison for Whanin Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | ₩9.04 Billion | ₩13.60 Billion | ▼ -22.7% |
| 2024 | 0.86x | ₩20.69 Billion | ₩24.06 Billion | ▲ +10.4% |
| 2023 | 0.78x | ₩23.20 Billion | ₩29.77 Billion | ▲ +10.6% |
| 2022 | 0.70x | ₩16.85 Billion | ₩23.92 Billion | ▼ -46.8% |
| 2021 | 1.32x | ₩35.32 Billion | ₩26.66 Billion | ▲ +36.2% |
| 2020 | 0.97x | ₩22.75 Billion | ₩23.39 Billion | ▼ -26.4% |
| 2019 | 1.32x | ₩24.73 Billion | ₩18.70 Billion | ▲ +63.1% |
| 2018 | 0.81x | ₩17.45 Billion | ₩21.52 Billion | ▼ -6.1% |
| 2017 | 0.86x | ₩23.48 Billion | ₩27.17 Billion | ▼ -28.5% |
| 2016 | 1.21x | ₩19.82 Billion | ₩16.40 Billion | ▼ -9.5% |
| 2012 | 1.34x | ₩21.11 Billion | ₩15.80 Billion | ▲ +29.2% |
| 2011 | 1.03x | ₩15.12 Billion | ₩14.61 Billion | ▲ +18.0% |
| 2010 | 0.88x | ₩15.12 Billion | ₩17.24 Billion | ▼ -32.0% |
| 2009 | 1.29x | ₩18.61 Billion | ₩14.43 Billion | — |